“…The aforementioned strategy for the assembly of ouabagenin could be generally applied to a variety of other cardiotonic steroids (Scheme ). [49c], [49d] Thus, key intermediate 147 was successfully elaborated to diastereomeric cardenolides trewianin aglycon (12 steps, 14 % yield),[49a], [9d] 19‐hydroxysarmentogenin (12 steps, 8 % yield),[49a], [9d] panogenin (9 steps, 5 % yield)[49a] and 5‐ epi ‐panogenin (9 steps, 23 % yield)[49a], [49d] that have different configurations at the C5 and C11 stereocenters. In addition, these efforts provided sarmentologenin (14 steps, 7 % yield) that lacks C1‐oxygenation in comparison to ouabagenin.…”